Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL445035 | 0.81 | LMNA (0.40) | LMNA | |
| SCHEMBL6138643 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL12532431 | 0.79 | LMNA (0.39) | LMNA | |
| SCHEMBL35673 | 0.78 | LMNA (0.39) | LMNA | |
| SCHEMBL22092444 | 0.78 | LMNA (0.39) | LMNA | |
| SCHEMBL4932454 | 0.77 | LMNA (0.42) | LMNA | |
| SCHEMBL16746517 | 0.77 | LMNA (0.42) | LMNA | |
| SCHEMBL22806611 | 0.77 | LMNA (0.42) | LMNA | |
| SCHEMBL10115033 | 0.75 | — | — | |
| SCHEMBL28395575 | 0.75 | LMNA (0.31) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3526306-A1 | PHOTOCHROMIC ARTICLE | SDC Technologies, Inc. (US) | 2019-08-21 | — | — | EP | disclosed |
| WO-2019067838-A1 | PHOTOCHROMIC ARTICLE | SDC TECHNOLOGIES, INC. (US) | 2019-04-04 | — | — | WO | disclosed |
| US-20170114247-A1 | PROCESSES FOR MOISTURE SCAVENGING IN PREPARING POLYURETHANE COATINGS AND COMPOSITIONS THEREFOR | Achiewell, LLC | 2017-04-27 | — | — | US | disclosed |
| EP-1702919-B1 | NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE | MSD KK (JP) | 2012-05-30 | — | — | EP | disclosed |
| EP-2454246-A2 | SOLVATES OF DOCETAXEL | Przedsiebiorstwo Produkcyjno-Wdrozeniowe (PL) | 2012-05-23 | — | — | EP | disclosed |
| US-20120071674-A1 | SOLVATES OF DOCETAXEL | PRZEDSIEBIORSTWO PRODUKCYJNO-WDROZENIOWE IFOTAM SP. Z O.O. (PL) | 2012-03-22 | — | — | US | disclosed |
| WO-2010138010-A2 | SOLVATES OF 4-ACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1,7β,10β-TRIHYDROXY-9-OXO-TAX-11 -EN- 13α-YL (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE | Przedsiębiorstwo Produkcyjno-Wdrożeniowe (PL) | 2010-12-02 | — | — | WO | disclosed |
| US-7728025-B2 | 2-heteroaryl-substituted benzimidazole derivative | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| EP-2001965-A1 | COATING COMPOSITIONS, ARTICLES, AND METHODS OF COATING ARTICLES | SDC COATINGS, INC. (US) | 2008-12-17 | — | — | EP | disclosed |
| US-20080070928-A1 | Novel 2-Heteroaryl-Substituted Benzimidazole Derivative | MSD K.K. (JP) | 2008-03-20 | — | — | US | disclosed |
| EP-1099703-B1 | Process for preparing alkoxysilanes | DEGUSSA (DE) | 2004-08-11 | — | — | EP | disclosed |
| WO-2004033573-A1 | FLEXIBLE EMISSIVE COATINGS FOR ELASTOMER SUBSTRATES | LORD CORPORATION (US) | 2004-04-22 | — | — | WO | disclosed |
| EP-0997468-B1 | Process for neutralising or reducing chlorine content of alkoxy silanes or alkoxysilane-based compositions | DEGUSSA (DE) | 2004-01-21 | — | — | EP | disclosed |
| US-6323356-B1 | REACTING HALOGENOSILANE WITH ALCOHOL IN THE PRESENCE OF METALLIC MAGNESIUM TO FORM A CRUDE PRODUCT; ISOLATING AN ALKOXYSILANE | DEGUSSA-HUELS AKTIENGESELLSCHAFT (DE) | 2001-11-27 | — | — | US | disclosed |
| EP-1099703-A2 | Process for preparing alkoxysilanes | Degussa AG (DE) | 2001-05-16 | — | — | EP | disclosed |
| US-6177584-B1 | Process for neutralizing and reducing residual halogen contents in alkoxysilanes or alkoxysilane-based compositions | DEGUSSA-HUELS AKTIENGESELLSCHAFT (DE) | 2001-01-23 | — | — | US | disclosed |
| EP-0997468-A2 | Process for neutralising or reducing chlorine content of alkoxy silanes or alkoxysilane-based compositions | Degussa-Hüls Aktiengesellschaft (DE) | 2000-05-03 | — | — | EP | disclosed |
| EP-0378430-B1 | Novel organosilicon compound and process for producing organosilicon compound | AGENCY IND SCIENCE TECHN (JP) | 1995-02-01 | — | — | EP | disclosed |
| US-5151538-A | ORGANOSILICON COMPOUND AND PROCESS FOR PRODUCING ORGANOSILICON COMPOUND | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1992-09-29 | — | — | US | disclosed |
| EP-0378430-A1 | Novel organosilicon compound and process for producing organosilicon compound | DIRECTOR-GENERAL OF THE AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1990-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071674-A1 | SOLVATES OF DOCETAXEL | TERT, TBCA, TAF11 | LMNA 3065/4885 |
| US-20080070928-A1 | Novel 2-Heteroaryl-Substituted Benzimidazole Derivative | GCK, GCKR, HK1 | LMNA 3434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.